Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 40 results found. Search for [ US DoJ ]

Results 20 to 40 of 40
PTI
October 4, 2018



Gina Krishnan
New Delhi, February 6, 2018
With the Delhi High Court's verdict, Daiichi Sankyo has scored a victory against former Ranbaxy promoters. But it won't end there.


PTI
February 1, 2018



BT Online
New Delhi, March 8, 2017
Develoment comes barely a week after the US assured India that the H1-B visas issue was not a priority for it and would be part of the larger immigration reforms package.


Reuters
November 4, 2016
Indian drug makers, most of which count the United States as their biggest export market, were the top losers on the key indexes on Friday.


BT Online
New Delhi, November 4, 2016
The Sensex fell further after the reports of criminal investigation of generic makers over suspected price collusion and closed  156 points lower.


BT Online
New Delhi, October 3, 2016
Market rallied buoyed by manufacturing PMI for September that came in above the 50-mark for the ninth straight month signalling expansion, and improving business conditions.


BT Online
New Delhi, October 3, 2016
Sunday night, a bunch of militants opened fire on an Indian army camp in north Kashmir, brewing fresh tensions between India and Pakistan.


Sajai Singh and Yajas Sethlur
September 7, 2016
The emails and communications in question are stored on Microsoft's servers in Ireland, and contained evidence relating to an ongoing drug and money laundering case in New York.


Reuters
Washington, July 8, 2016
The energy sector of the S&P was dragged lower by Exxon and Chevron as oil futures prices fell nearly 5 per cent after crude stockpiles fell slightly less than forecast.


Arpinder Singh
April 27, 2015
The business model to conduct operations, whether it is franchise or management, is immaterial to the risks that could arise around FCPA violation


Alexei Oreskovic
San Francisco, October 8, 2014
The lawsuit marks an escalation in the Internet industry's battle over gag orders by the US government on the nature and number of requests for private user information.


Aman Shah
Mumbai, September 17, 2014
The company said it had received a civil investigative demand (CID) from the U.S. Department of Justice (DOJ) and that it would fully cooperate with the investigation.


Chaitanya Kalbag
June 4, 2013
When I met Srinivasan at his India Cements office in December 2010, he spoke at length about his business and his passion for cricket: his company had traditionally employed some of India's best cricketers. His story is a reminder of the intertwining of politics, patronage, cricket and money.


Chaitanya Kalbag
June 5, 2013
Fortis Healthcare Executive Chairman Malvinder Singh, while rebutting Japanese firm Daiichi Sankyo's charges, says the company failed in growing the Ranbaxy business.


E. Kumar Sharma and Chaitanya Kalbag
June 4, 2013
The pharma major is still to get its Paonta Sahib and Dewas units back on track for inspection and approval by the FDA so that it can resume supplies to the US from these facilities.


E. Kumar Sharma
May 23, 2013
Ten days after the US Department of Justice announced that Ranbaxy had pleaded guilty and agreed to pay $500 million as settlement for having engaged in manufacturing violations, the battle lines have been drawn between the new and old managements of the company.


BT Online Bureau
Mumbai, May 23, 2013
Shares of the company opened on a weak note and further tanked 9.3 per cent to Rs 391 on the BSE. At NSE, the stock tumbled 9.37 per cent to Rs 390.65.


PTI
New Delhi, May 22, 2013
Drug maker Ranbaxy's Japanese promoters on Wednesday blamed the company's former Indian owners for concealing and misrepresenting critical information about US investigation into sale of adulterated drugs, and said it will pursue legal remedies.


BT Online Bureau
May 13, 2013
In the largest settlement by a generic medicine maker till date, its US subsidiary has pleaded guilty to felony charges relating to the manufacture and distribution of adulterated drugs made at two of drugmaker's manufacturing facilities in India.


PAGES 2 OF 2  12